bpc-157 fda warning news 2025 october moves toward easing restrictions on certain peptides FDA warns Texas medical spa
FDA warns Texas medical spa for Botox dispensing discrepancies RAPS On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Warning Letter to Platinum Biologics LLC for marketing umbilicalcordderived products including exosome products (NanoEx & Nano Xsomes) without approval. 83% of peptide aware Americans want the FDA to make peptides more accessible News Channel 3 12 Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law
Pay in 4 interest-free payments of $6.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3


